Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosa

Microbes and Infection

Volumn 10, Issue 12-13, 2008, Pages 1244-1250

  Murphey, E D ^a,b   Sherwood, E R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Bacterial infection; Mice; Peptidoglycan; TLR4; Tolerance

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; COLONY FORMING UNIT; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; INNATE IMMUNITY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANIMALS; CELL WALL; GRAM-POSITIVE BACTERIA; IMMUNITY, INNATE; INFLAMMATION; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PEPTIDOGLYCAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 54849425532     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.07.021     Document Type: Article

References (28)

1. Greisman S.E., Young E.J., and Carozza Jr. F.A. Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. J. Immunol. 103 (1969) 1223-1236
2. Lehner M.D., Ittner J., Bundschuh D.S., van R.N., Wendel A., and Hartung T. Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect. Immun. 69 (2001) 463-471
3. Murphey E.D., Fang G., Varma T.K., and Sherwood E.R. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma. Shock 27 (2007) 289-295
4. Varma T.K., Durham M., Murphey E.D., Cui W., Huang Z., Lin C.Y., Toliver-Kinsky T., and Sherwood E.R. Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice. Infect. Immun. 73 (2005) 7340-7347
5. Murphey E.D., Fang G., and Sherwood E.R. Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus. Shock 29 (2008) 512-518
6. Meng X., Brown J.M., Ao L., Shames B.D., Banerjee A., and Harken A.H. Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density. Shock 12 (1999) 25-31
7. Lastres-Becker I., Cartmell T., and Molina-Holgado F. Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. J. Neuroimmunol. 173 (2006) 108-116
8. Konturek P.C., Brzozowski T., Konturek S.J., Taut A., Kwiecien S., Pajdo R., Sliwowski Z., and Hahn E.G. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins. Digestion 59 (1998) 284-297
9. Poltorak A., He X.L., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
10. Beeson P.B. Tolerance to bacterial pyrogens: I. Factors influencing its development. J. Exp. Med. 86 (1947) 29-38
11. Abe M., Tokita D., Raimondi G., and Thomson A.W. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur. J. Immunol. 36 (2006) 2483-2493
12. Ferlito M., Romanenko O.G., Ashton S., Squadrito F., Halushka P.V., and Cook J.A. Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. J. Leukoc. Biol. 70 (2001) 821-829
13. Bautista A.P., and Spitzer J.J. Cross-tolerance between acute alcohol intoxication and endotoxemia. Alcohol Clin. Exp. Res. 20 (1996) 1395-1400
14. Murphey E.D., and Traber D.L. Protective effect of tumor necrosis factor-alpha against subsequent endotoxemia in mice is mediated, in part, by interleukin-10. Crit. Care Med. 29 (2001) 1761-1766
15. Aneja R., Odoms K., Dunsmore K., Shanley T.P., and Wong H.R. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J. Immunol. 177 (2006) 7184-7192
16. Sato S., Nomura F., Kawai T., Takeuchi O., Muhlradt P.F., Takeda K., and Akira S. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165 (2000) 7096-7101
17. Wang J.H., Doyle M., Manning B.J., Blankson S., Wu Q.D., Power C., Cahill R., and Redmond H.P. Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J. Immunol. 170 (2003) 14-18
18. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., and Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166 (2001) 5161-5167
19. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
20. Nakayama K., Okugawa S., Yanagimoto S., Kitazawa T., Tsukada K., Kawada M., Kimura S., Hirai K., Takagaki Y., and Ota Y. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 279 (2004) 6629-6634
21. Zacharowski K., Frank S., Otto M., Chatterjee P.K., Cuzzoorea S., Hafner C., Pfeilschifter J., and Thiemermann C. Lipoteichoic acid induces delayed protection in the rat heart - A comparison with endotoxin. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1521-1528
22. Ausobsky J.R., Cheadle W.G., Brosky B.G., and Polk Jr. H.C. Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice. Br. J. Surg. 71 (1984) 151-153
23. O'Brien G.C., Wang J.H., and Redmond H.P. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J. Immunol. 174 (2005) 1020-1026
24. Dziarski R. Peptidoglycan recognition proteins (PGRPs). Mol. Immunol. 40 (2004) 877-886
25. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., Coyle A.J., DiStefano P.S., Bertin J., Sansonetti P.J., and Philpott D.J. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300 (2003) 1584-1587
26. Mullaly S.C., and Kubes P. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J. Immunol. 177 (2006) 8154-8163
27. Wheeler D.S., Lahni P.M., Denenberg A.G., Poynter S.E., Wong H.R., Cook J.A., and Zingarelli B. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock (2008) (ePub ahead of print. PMID: 18431464)
28. Munoz C., Carlet J., Fitting C., Misset B., Bleriot J.P., and Cavaillon J.M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88 (1991) 1747-1754